PCNT anticorps

N° du produit ABIN2333274

Détail du produit anti-PCNT anticorps

Antigène: PCNT (Pericentrin (PCNT))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PCNT est non-conjugé

Application: Western Blotting (WB), Immunochromatography (IC)

Réactivité croisée: Humain

Réactivité croisée (Details): Calculated cross reactivity: Hu

Attributs du produit: Pericentrin (Kendrin, Pericentrin-B, PCNT, KIAA0402, PCNT2)

Purification: Purified by immunoaffinity chromatography.

Immunogène: Synthetic linear peptide corresponding to human Pericentrin (KLH).

Information d'application

Indications d'application: Optimal working conditions should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Supplied as a liquid in 0.1M Tris-glycine, pH 7.4, 150 mM sodium chloride, 0.05 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: -20°C

Détails sur PCNT

Antigène: PCNT (Pericentrin (PCNT))

Autre désignation: Pericentrin (PCNT Produits)

Synonymes: anticorps AKAP450, anticorps CG13459, anticorps CG18648, anticorps CG33957, anticorps CG6735, anticorps CP309, anticorps Cp309, anticorps D-PLP, anticorps DPLP, anticorps Dmel\\CG33957, anticorps Dplp, anticorps PACT, anticorps PLP, anticorps Plp, anticorps d-plp, anticorps dPLP, anticorps dplp, anticorps l(3)s2172, anticorps pPlp, anticorps KEN, anticorps MOPD2, anticorps PCN, anticorps PCNT2, anticorps PCNTB, anticorps PCTN2, anticorps SCKL4, anticorps DIP2A, anticorps AW476095, anticorps C86676, anticorps Pcnt2, anticorps kendrin, anticorps m239Asp, anticorps m275Asp, anticorps pericentrin, anticorps Pericentrin-like protein, anticorps pericentrin (kendrin), anticorps LOC100055203, anticorps Plp, anticorps PCNT, anticorps pcnt, anticorps Pcnt

NCBI Accession: NP_006022

Pathways: Sensory Perception of Sound, M Phase, SARS-CoV-2 Protein Interactome